Evidence map›Paper›PMID 41766747›Full record

ArticleFrontiers in surgery2025

Mammary myofibroblastic sarcoma with lung metastasis: a case report and literature review.

Miri Ryu, Youn Joo Jung, Seungju Lee, Seok Kyung Kang, Meehyun Lee, Jee Yeon Kim, Kyung Jin Nam, Kyeyoung Lee, Ji Hyeon Joo, Jae Joon Kim and 1 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Miri RyuDepartment of Surgery, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.
Youn Joo JungDepartment of Surgery, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.
Seungju LeeDepartment of Surgery, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.
Seok Kyung KangDepartment of Surgery, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.
Meehyun LeeDepartment of Surgery, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.
Jee Yeon KimDepartment of Pathology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.
Kyung Jin NamDepartment of Radiology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.
Kyeyoung LeeDepartment of Radiology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.
Ji Hyeon JooDepartment of Radiation Oncology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.
Jae Joon KimDepartment of Hematology and Oncology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.
Hyun Yul KimDepartment of Surgery, Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Gyeongnam, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myofibroblastic sarcomas of the breast are rare, leading to very few reports on their prognosis and metastasis potential. We report a case of lung metastasis from a mammary low-grade myofibroblastic sarcoma. A 55-year-old woman with no remarkable past medical history presented to a local clinic with a palpable mass in her left breast that had persisted for 3 weeks. Vacuum-assisted excisional biopsy initially suggested a diagnosis of a malignant phyllodes tumor. Subsequent wide excision with clear surgical margins led to a confirmed diagnosis of myofibroblastic sarcoma. No additional treatments, such as chemotherapy or radiotherapy, were administered. Four years later, lung metastases were detected on chest computed tomography. The patient subsequently underwent wedge resection of the lung. Three years later, metastasis to the cervical lymph nodes was discovered. Owing to tumor emboli, the patient ultimately died from brain infarction. No consensus guidelines for standard treatment exist due to the scarcity of the disease. Although surgical resection remains the most reasonable treatment option, additional therapies should be considered to reduce the risk of metastatic spread to other organs.

Indexed as

breastlungmetastasismyofibroblasticsarcoma

Identifiers

PMID41766747
PMCPMC12935901

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.